Delivery Order SPE2DB20D9332-SPE2DB23FV3A8
Award Date 1/5/23
Potential Completion Date 1/6/23
Potential Value $407
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,066.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 1,440 unit/mL syringes of HAVRIX, a hepatitis A vaccine. The contract has a period of performance from January 19-20, 2023, with all work to be performed in Park Ridge, Illinois. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports military readiness by procuring, managing and distributing medical supplies to armed forces...
- <p>This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of 1,440 units of HAVRIX vaccine in 1 ml syringes. The potential value of this firm fixed price contract is $2,033.40. Performance will occur in Park Ridge, Illinois, with delivery required no later than January 25, 2023. No set-aside provisions were applied to this award in support of the Defense Logistics Agency's medical supply chain responsibilities.</p>
- The Defense Logistics Agency awarded a $1,220 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 1,440 units of HAVRIX vaccine in pre-filled syringes. The vaccine will be delivered to a location in Park Ridge, Illinois by February 13, 2023 to support the Department of Defense's immunization programs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to fulfill vaccine...
- The Defense Logistics Agency awarded an $813 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 1,440 units of HAVRIX vaccine in 1 ml pre-filled syringes with an anticipated completion date of September 21, 2023. No set-aside provision was specified in the award. The order was issued under an unspecified agency-wide indefinite-delivery/indefinite-quantity contract vehicle to support the DLA's medical supply chain requirements. DMS...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at two thousand four hundred forty dollars and eight cents to DMS Pharmaceutical Group Inc. to supply one thousand four hundred forty units of HAVRIX, a hepatitis A vaccine presented as one milliliter pre-filled syringes. Performance will take place in Park Ridge, Illinois over a one day period from February 16 to 17, 2023. The DLA procures medical supplies and equipment to support Department of Defense programs....
- This delivery order, valued at $9,073.60, was awarded on August 4, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of HAVRIX 1,440 unit/mL syringes. The award represents a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and was funded by the Defense Logistics Agency's Medical Supply Chain division. This contract carries no set-aside designation, allowing DMS...
- This delivery order from the Defense Logistics Agency awards DMS Pharmaceutical Group Inc. a firm fixed price contract valued at four hundred six dollars to supply 1,440 unit/ml syringes of HAVRIX, a hepatitis A vaccine, for delivery by January 13, 2023. The Defense Logistics Agency is responsible for worldwide logistics support of the Department of Defense, stocking medical supplies for military treatment facilities around the globe. This small order for HAVRIX vaccines aligns with the agency's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 6, 2025, for 1,440 units of HAVRIX 1,440 Unit/ML syringes with a ceiling value of $2,268.40. This delivery order, issued without a set-aside designation, is part of the company's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499.9 million through November 2026. The contract is...
- DMS Pharmaceutical Group Inc. was awarded an $813 firm fixed price delivery order against the Defense Logistics Agency's Pharmaceutical Prime Vendor contract to supply 1,440 unit/mL syringes of HAVRIX, a hepatitis A vaccine. Performance will take place in Park Ridge, Illinois with all supplies delivered by February 6, 2023. No set-aside provisions were applied to this order for pharmaceutical products stocked under the Agency's prime vendor program, which leverages commercial distributors to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,253.44 to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the contract, DMS Pharmaceutical Group will provide 1,440 units of HAVRIX, a hepatitis A vaccine, to the Defense Logistics Agency by February 6, 2023. The place of performance is listed as the prime contractor's location in Park Ridge. No additional context was provided regarding the Defense Logistics Agency's programs or any associated...